Compliance (n=172) | Non-compliance (n=258) | P value | |
City | 0.002 | ||
Clermont-Ferrand | 123 (71.5) | 147 (57.0) | |
Lyon | 49 (28.5) | 111 (43.0) | |
Age (years) | 72.9±13.6 | 73.8±15.4 | 0.53 |
Male sex | 95 (55.2) | 152 (58.9) | 0.45 |
Reasons for admission | |||
Infection (including sepsis and septic shock) | 83 (48.3) | 122 (47.3) | 0.84 |
Acute respiratory symptoms | 79 (45.9) | 121 (46.9) | 0.84 |
Hepato-digestive symptoms | 30 (17.4) | 57 (22.1) | 0.24 |
Cardiac symptoms | 31 (18.0) | 31 (12.0) | 0.08 |
Uro-nephrotic symptoms | 10 (5.8) | 13 (5.0) | 0.73 |
Metabolic disorders | 6 (3.5) | 12 (4.7) | 0.56 |
Neurological symptoms | 23 (13.4) | 33 (12.8) | 0.86 |
Traumatology | 8 (4.7) | 11 (4.3) | 0.85 |
Other | 23 (13.4) | 48 (18.6) | 0.15 |
Organ failure | 160 (93.0) | 234 (90.7) | 0.39 |
COVID-19 infection | 35 (20.3) | 41 (15.9) | 0.24 |
Comorbidities | 161 (93.6) | 242 (93.8) | 0.94 |
Diabetes | 34 (19.8) | 49 (19.0) | 0.84 |
High blood pressure | 82 (47.7) | 111 (43.0) | 0.34 |
Heart failure | 31 (18.0) | 37 (14.3) | 0.31 |
Chronic renal failure | 24 (14.0) | 29 (11.2) | 0.40 |
Respiratory failure | 14 (8.1) | 30 (11.6) | 0.24 |
Cirrhosis | 13 (7.6) | 19 (7.4) | 0.94 |
Immunosuppression | 68 (39.5) | 133 (51.6) | 0.01 |
Other | 38 (22.1) | 43 (16.7) | 0.16 |
Dependancy | 0.40 | ||
Total | 16 (9.3) | 30 (11.6) | |
Partial | 74 (43.0) | 95 (36.8) | |
No | 82 (47.7) | 133 (51.6) | |
Hospitalisation in ICU | 111 (64.5) | 126 (48.8) | 0.001 |
Hospital stay (days) | 7 (3; 13) | 6 (2; 13) | 0.55 |
Visits | 154 (89.5) | 208 (80.6) | 0.01 |
Surrogate | 77 (44.8) | 129 (50.0) | 0.29 |
Intervention of MPCT | 11 (6.4) | 18 (7.0) | 0.81 |
Data are presented as the number of patients (percentages), mean ±SD or median (25th; 75th percentiles).
ICU, intensive care unit; MPCT, mobile palliative care team.